Compare PTGX & ALSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTGX | ALSN |
|---|---|---|
| Founded | 2006 | 1915 |
| Country | United States | United States |
| Employees | N/A | 4000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 9.5B |
| IPO Year | 2016 | 2011 |
| Metric | PTGX | ALSN |
|---|---|---|
| Price | $138.00 | $124.29 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 7 |
| Target Price | $108.23 | ★ $117.57 |
| AVG Volume (30 Days) | 593.6K | ★ 836.9K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.84% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.05 | ★ 1.33 |
| Revenue | N/A | ★ $3,010,000,000.00 |
| Revenue This Year | $874.25 | $94.98 |
| Revenue Next Year | N/A | $5.30 |
| P/E Ratio | $2,645.60 | ★ $87.45 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $50.49 | $76.01 |
| 52 Week High | $143.29 | $137.62 |
| Indicator | PTGX | ALSN |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 48.92 |
| Support Level | N/A | $112.48 |
| Resistance Level | N/A | $118.64 |
| Average True Range (ATR) | 0.00 | 3.37 |
| MACD | 0.00 | -0.12 |
| Stochastic Oscillator | 0.00 | 38.34 |
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
Allison Transmission is the largest manufacturer of fully automatic transmissions for medium- and heavy-duty commercial vehicles. Its automatic transmissions allow customers to achieve better fuel and operator efficiency than less expensive manual and automated manual transmissions. Allison serves several end markets, including on- and off-highway equipment and military vehicles. Its on-highway business commands approximately 60% global market share. The company's transmissions can be found in Class 4-8 trucks, buses, and a limited number of large passenger vehicles (heavy-duty pickup trucks and motorhomes). Allison also produces commercial hybrid propulsion systems and is developing fully electric powertrains.